Intuniv®
1, 2, 3 and 4mg | Tablets
The pharmacist has dispensed Intuniv® 1, 2, 3 or 4mg to you. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of this medicine has therefore instructed TBR Nederland to reimburse to the patient the Personal Contribution charged.
Dose | 1, 2, 3 and 4mg |
Type | Tablets |
Active ingredient | GUANFACINE |
The Reimbursement Scheme Regulation of Intuniv® is limited to children and adolescents 6 to 17 years of age who are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) for whom stimulants are unsuitable, are not well tolerated or have been demonstrated that they are not effective.
The Personal Contribution that is demonstrably charged to the patient by the health insurer for Intuniv® will be fully reimbursed from 1 January 2019 with a maximum of € 250 per patient per year. He / she can claim this at TBR Nederland.
Only patients or their carer can submit a claim online for the Personal Contribution amount they paid for Intuniv® 1, 2, 3 or 4mg. Pharmacists cannot submit claims on behalf of patients for this medicine.
For this Reimbursement Scheme no closing date has been determined yet.
Patients can claim online and will receive their reimbursement within 5 working days.
If you need any assistance please read our Frequently Asked Questions.
Still does not work? Please contact our Servicedesk via e-mail or call the Intuniv® service-number 088 - 0026759
Quickly check the maximum contribution you have to pay for your medicine